More CB1 Protein in the Periaqueductal Grey Did Not Mean a Stronger Pain-Response Effect
After repeated alcohol exposure, mice showed increased CB1 protein in the periaqueductal grey alongside reduced antinociceptive responses to a cannabinoid agonist. One regional protein measurement could not explain the whole behavioral outcome.
The directions did not match a simple receptor-count account
Pava and colleagues found elevated CB1 protein in the periaqueductal grey after the ethanol regimen. In the separate behavioral cohort, WIN55,212-2 produced a smaller effect on the hot-plate response. The study therefore did not support an explanation that relied only on reduced protein in that region.
Pain-related circuitry extends beyond one sampled region
The authors discuss other supraspinal structures, spinal mechanisms and peripheral CB1 contributions that could participate in cannabinoid antinociception. Changes elsewhere could influence the outcome even if protein increased in the sampled periaqueductal tissue. The paper did not establish which alternative location accounted for the reduced response.
Protein amount is only part of a circuit explanation
The tissue assay did not directly measure signaling efficiency, and receptor and behavioral values were not paired within individual animals. The findings consequently favor a distributed research question over a single-region explanation. They concern an acute thermal-response assay in mice, not a patient’s pain experience or proof that cannabis pain relief can be predicted from receptor quantity.
Related analysis: The tested agonist and direction of alcohol–cannabinoid cross-tolerance.
Research cited
Pava MJ, Blake EM, Green ST, Mizroch BJ, Mulholland PJ, Woodward JJ. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology (2012).
